Insufficient scRNA-seq data for expression of FOXN4 at single-cell level.
Insufficient scRNA-seq data for expression of FOXN4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 76% | 14.58 | 2000 / 2642 | 32% | 0.86 | 224 / 705 |
liver | 70% | 54.18 | 159 / 226 | 30% | 2.87 | 123 / 406 |
uterus | 76% | 89.95 | 129 / 170 | 21% | 1.27 | 98 / 459 |
kidney | 94% | 41.58 | 84 / 89 | 2% | 0.04 | 16 / 901 |
prostate | 73% | 16.91 | 178 / 245 | 15% | 0.35 | 74 / 502 |
intestine | 76% | 38.95 | 730 / 966 | 2% | 0.07 | 10 / 527 |
adipose | 73% | 39.45 | 884 / 1204 | 0% | 0 | 0 / 0 |
breast | 60% | 24.82 | 276 / 459 | 9% | 0.34 | 96 / 1118 |
muscle | 64% | 25.14 | 517 / 803 | 0% | 0 | 0 / 0 |
ovary | 24% | 3.03 | 44 / 180 | 38% | 2.45 | 162 / 430 |
skin | 57% | 16.76 | 1039 / 1809 | 4% | 0.12 | 19 / 472 |
esophagus | 50% | 9.39 | 722 / 1445 | 7% | 0.19 | 12 / 183 |
bladder | 48% | 9.29 | 10 / 21 | 7% | 0.94 | 36 / 504 |
lung | 45% | 26.67 | 259 / 578 | 7% | 0.36 | 81 / 1155 |
adrenal gland | 22% | 2.32 | 58 / 258 | 22% | 0.46 | 51 / 230 |
stomach | 13% | 1.16 | 45 / 359 | 2% | 0.04 | 7 / 286 |
thymus | 13% | 1.42 | 83 / 653 | 0% | 0.01 | 3 / 605 |
heart | 11% | 1.24 | 96 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 10% | 2.73 | 140 / 1335 | 0% | 0 | 0 / 0 |
spleen | 7% | 0.59 | 16 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.42 | 2 / 45 |
pancreas | 3% | 0.19 | 9 / 328 | 1% | 0.08 | 2 / 178 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
peripheral blood | 1% | 0.14 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0036302 | Biological process | atrioventricular canal development |
GO_0001947 | Biological process | heart looping |
GO_0008016 | Biological process | regulation of heart contraction |
GO_0021514 | Biological process | ventral spinal cord interneuron differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0060579 | Biological process | ventral spinal cord interneuron fate commitment |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035881 | Biological process | amacrine cell differentiation |
GO_0010842 | Biological process | retina layer formation |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
Gene name | FOXN4 |
Protein name | Forkhead box N4 Forkhead box protein N4 FOXN4 protein |
Synonyms | |
Description | FUNCTION: Transcription factor essential for neural and some non-neural tissues development, such as retina and lung respectively. Binds to an 11-bp consensus sequence containing the invariant tetranucleotide 5'-ACGC-3'. During development of the central nervous system, is required to specify the amacrine and horizontal cell fates from multipotent retinal progenitors while suppressing the alternative photoreceptor cell fates through activating DLL4-NOTCH signaling. Also acts synergistically with ASCL1/MASH1 to activate DLL4-NOTCH signaling and drive commitment of p2 progenitors to the V2b interneuron fates during spinal cord neurogenesis. In development of non-neural tissues, plays an essential role in the specification of the atrioventricular canal and is indirectly required for patterning the distal airway during lung development (By similarity). . |
Accessions | A6H901 S4R3U5 Q96NZ1 ENST00000299162.10 [Q96NZ1-1] A4FUA3 A0A0C4DG65 ENST00000423960.1 ENST00000355216.5 [Q96NZ1-3] ENST00000468516.1 |